
    
      PRIMARY OBJECTIVE

      I. To determine if COX-2 inhibition with celecoxib significantly increases apoptosis in human
      adenocarcinoma of the prostate.

      SECONDARY OBJECTIVES

      I. To determine if COX-2 inhibition with celecoxib reduces levels of Prostaglandin E2 and
      androgen receptor in fresh tumor tissue collected at prostatectomy

      II. To collect pre- and postoperative serum Prostate Specific Antigen (PSA) for exploratory
      analyses

      III. To determine the effect of celecoxib on adverse effects, perioperative surgical
      complications and post surgery analgesic use
    
  